digital currency market value Knowledge

Since the release of "Keba Article", the refinancing of the first unprofitable enterprise in Shanghai Stock Exchange has been approved, and Dizhe Medicine announced that the company's private placement plan has been approved by Shanghai Stock Exchange. This is the first time that the refinancing of the unprofitable enterprise on the Shanghai Stock Exchange has been approved since the release of "Keba Article". (science and technology innovation board Daily)Jingmen, the Yiwei Lithium Energy Super Energy Storage Factory, was put into operation, with the largest production capacity in Central China. Following the opening and operation of Jingjing High-speed Railway, on December 10th, the Yiwei Lithium Energy 60GWh Super Energy Storage Factory project was officially put into operation in the new energy and new materials industrial park of Duodao District, Jingmen High-tech Zone, becoming a lithium battery production base with the largest production capacity and the longest industrial chain in Central China. The total investment of this project is 10.8 billion yuan, and the first phase covers an area of about 700 mu. It mainly produces MB56 large iron-lithium energy storage batteries, and its cell capacity and cycle times are 25% and 20% higher than those of the same industry products respectively, which are widely used in electric energy storage, ship energy storage and other fields. Taking an electric ship as an example, the voyage distance can be increased by about 40% by using MB56 battery, and the battery life can be extended by about two years.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)

Beijing Auto: BAIC Investment and Hyundai Motor invested US$ 1.095 billion in Beijing Hyundai. Beijing Auto announced that on December 11, 2024, BAIC Investment and Hyundai Motor entered into an agreement, and both parties agreed to jointly invest US$ 1.095 billion in Beijing Hyundai according to the proportion of their respective registered capital, and both parties invested US$ 548 million respectively. The capital injection will be carried out in stages. After the capital injection is completed, the registered capital of Beijing Hyundai will increase to US$ 4.074 billion, and Beijing Hyundai will still be owned by BAIC Investment and Hyundai Motor respectively, and will continue to be accounted for as a joint venture of the Company.MERO, the Czech pipeline operator: The oil transportation to the Czech Republic through the "Friendship" pipeline continues to run as planned.UN Secretary-General Guterres: I fully believe that the Syrian people can choose their own destiny.

The probability of the Bank of Japan raising interest rates this month doesn't seem to increase the strength of the US/Japan again. Justin Low, an analyst at Forexlive, a financial website, said that the possibility of the Bank of Japan raising interest rates this month was very low from the beginning, and earlier today, the ratio was about 30%. There has just been a sudden report that some policy makers of the Bank of Japan may support raising interest rates in December, but they also think it is unnecessary to rush because they think the cost of waiting for raising interest rates is "very small". After this news, the possibility of the Bank of Japan raising interest rates further dropped to about 23%. This, in turn, led to buying against the yen, while the yen fell. In the initial reaction, USD/JPY once fell to a low of 150.99, but then rose to around 152.30.India's NIFTY metal index rose by 1.25%.Iran's Supreme Leader Ayatollah Ali Khamenei: Since September, Iran has issued a warning to the Assad government about the threat, but it has ignored the "enemy".